Insider Shareholders with Direct Ownership of Vera Therapeutics, Inc. (VERA)
This section provides a comprehensive overview of the insiders with direct ownership of Vera Therapeutics, Inc. (VERA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Vera Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Sofinnova Venture Partners X, L.P.
> 10% Shareholder |
3,467,156 | 0 | 3,467,156 $117 Million | 3 |
Feb 06, 2023
Added 7.61%
|
|
Marshall Fordyce
PRESIDENT AND CEO |
626,330 | 401,876 | 143,603 $4.84 Million | 49 |
Jan 08, 2025
Reduced 1.29%
|
| 0 | 30,000 | 131,553 $4.43 Million | 3 |
Oct 28, 2024
Reduced 0.15%
|
|
|
Sean Grant
CHIEF FINANCIAL OFFICER |
174,113 | 114,113 | 78,683 $2.65 Million | 6 |
Jan 16, 2024
Added 25.02%
|
|
Jason S Carter
Chief Legal Officer |
53,000 | 0 | 53,000 $1.79 Million | 1 |
Nov 18, 2024
Added 50.0%
|
|
Joseph R Young
SVP, FINANCE, CHIEF ACCT OFFCR |
81,461 | 36,551 | 51,206 $1.73 Million | 9 |
May 16, 2024
Reduced 4.65%
|
|
Joanne Curley
Chief Development Officer |
102,806 | 102,669 | 26,962 $908,619 | 36 |
Aug 21, 2023
Reduced 5.24%
|
|
Kurt Von Emster
Director |
17,828 | 0 | 17,828 $600,803 | 1 |
May 17, 2021
Added 50.0%
|
|
Celia Lin
Chief Medical Officer |
12,500 | 1,490 | 11,010 $371,037 | 2 |
Aug 21, 2023
Reduced 11.92%
|